FIELD: chemistry; pharmaceutics.
SUBSTANCE: group of inventions relates to versions of a pharmaceutical composition for preventing and/or treating an infectious disease of microbial aetiology, to the use of one of the compositions for preventing and/or treating an infectious disease of microbial etiology in a subject and to a method for preparing it. Disclosed compositions include a therapeutically or prophylactically effective amount methanesulphonate (5Z)-5-[(4-chlorophenyl)methylidene]-3-(2-{4-[2-(2,4-difluorophenyl)-2-hydroxy-3-(1,2,4-triazole-1-yl)propyl]piperazin-1-yl}-2-oxoethyl)-1,3-thiazolidine-2,4-dione and modified β-cyclodextrin in molar ratio of 1:2-1:5, where modified β-cyclodextrin is 2-hydroxypropyl-β-cyclodextrin or sulphobutyl ether-β-cyclodextrin.
EFFECT: group of inventions provides creating compositions characterized by high solubility, stability and efficacy, suitable for oral and parenteral administration.
27 cl, 10 dwg, 3 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| NEW POTENTIAL ANTIFUNGAL AGENTS BASED ON THIAZOLIDINE-2,4-DIONE AND TRIAZOLE | 2023 | 
 | RU2814730C1 | 
| HYBRID AMIDES BASED ON TRIAZOLE AND THIAZOLIDINE HAVING ANTIMICROBIAL ACTIVITY | 2018 | 
 | RU2703997C1 | 
| GLYCOPEPTIDE ANTIBIOTIC SALT AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2023 | 
 | RU2827992C1 | 
| 3,5-SUBSTITUTED THIAZOLIDINE-2,4-DIONE DERIVATIVES, HAVING ANTIMICROBIAL ACTIVITY | 2018 | 
 | RU2690161C1 | 
| PHARMACEUTICAL COMPOSITION CONTAINING LYSINE, PROLINE AND TRITERPENIC ACID DERIVATIVES FOR TREATING AND PREVENTING VIRAL INFECTIONS CAUSED BY RNA- AND DNA-CONTAINING VIRUSES, SUCH AS: INFLUENZA, HERPES, HERPES ZOSTER, HUMAN PAPILLOMA, ADENOVIRUSES, AS WELL AS BACTERIAL INFECTIONS CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE MICROORGANISMS | 2013 | 
 | RU2535052C1 | 
| HYBRID ETHERS BASED ON DERIVATIVES OF THIAZOLIDINE-2,4-DIONA AND AZOLES (1H-1,3-IMIDAZOLE AND 1H-1,3,4-TRIAZOLE) AND APPLICATION THEREOF | 2017 | 
 | RU2662153C1 | 
| PERINDOPRIL INCLUSION COMPLEXES | 2005 | 
 | RU2372353C2 | 
| THERAPEUTIC COMPOSITIONS | 2004 | 
 | RU2358729C2 | 
| ANTIBACTERIAL COMPOSITION OF GRAMICIDIN C, A METHOD OF ITS PRODUCTION AND USE | 2022 | 
 | RU2800287C1 | 
| ANTIFUNGAL COMPOSITIONS FOR ORAL USING | 1994 | 
 | RU2118899C1 | 
Authors
Dates
2024-12-09—Published
2023-10-10—Filed